Literature DB >> 9766389

Suppressive effect of vagal afferents on the activity of the trigeminal spinal neurons related to the jaw-opening reflex in rats: involvement of the endogenous opioid system.

M Takeda1, T Tanimoto, K Ojima, S Matsumoto.   

Abstract

The purpose of the present study is to test the hypothesis that via the endogenous pain control system, vagal afferent input modulates the activity of the trigeminal spinal nucleus oralis (TSNO) related to the tooth pulp (TP)-evoked jaw-opening reflex (JOR). Extracellular single-unit recordings were made from 36 TSNO units responding to TP electrical stimulation with a constant temporal relationship to a digastric electromyogram (dEMG) signal in 26 pentobarbital-anesthetized rats. The activity of 36 TSNO neurons and the amplitude of the dEMG increased proportionally during 1.0-3.5 times the threshold for JOR. Some of these neurons (4 out of 5) were also excited by chemical stimulation (bradykinin, 1-2 microl, 1 mM) of TP. In 31 out of 36 TSNO neurons (86%), their activities during tooth pulp stimulation were suppressed by conditioning stimulation of the right vagus nerve. The suppressive effect of vagal afferent stimulation occurred at conditioning-test intervals of 20-150 ms after the onset of the stimulation, and its maximal suppressive effect occurred at approximately 50 ms. The mean time course of this suppressive effect paralleled that of the dEMG. After administration of naloxone (0.5 and 1.0 mg/kg, i.v.), an opiate receptor blocker, the suppressive effect on the activity of TSNO neurons (6 out of 8) was significantly attenuated at the conditioning-test interval of 50 ms compared to the control (p < 0.01). These results suggested that vagal afferent input inhibits nociceptive transmission in the TSNO related to TP-evoked JOR and this inhibitory effect may occur via the endogenous opioid system in rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766389     DOI: 10.1016/s0361-9230(98)00059-8

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Role of capsaicin-sensitive primary afferent inputs from the masseter muscle in the C1 spinal neurons responding to tooth-pulp stimulation in rats.

Authors:  M Takeda; T Tanimoto; M Ito; M Nasu; S Matsumoto
Journal:  Exp Brain Res       Date:  2005-01       Impact factor: 1.972

2.  N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists suppress the superior sagittal sinus-evoked activity of C1 spinal neurons responding to tooth pulp electrical stimulation in rats.

Authors:  Yoshinobu Fujimi; Mamoru Takeda; Takeshi Tanimoto; Shigeji Matsumoto
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

3.  Nucleus accumbens facilitates nociception.

Authors:  Robert W Gear; Jon D Levine
Journal:  Exp Neurol       Date:  2011-03-31       Impact factor: 5.330

Review 4.  Convergence of cervical and trigeminal sensory afferents.

Authors:  Elcio J Piovesan; Pedro A Kowacs; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2003-10

5.  The relationship between resting arterial blood pressure and acute postoperative pain in endodontic patients.

Authors:  James Wayne King; Eric Bair; Derek Duggan; William Maixner; Asma A Khan
Journal:  J Orofac Pain       Date:  2012

Review 6.  Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management.

Authors:  Krishnan Chakravarthy; Hira Chaudhry; Kayode Williams; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2015-12

7.  Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine.

Authors:  Jordan L Hawkins; Lauren E Cornelison; Brian A Blankenship; Paul L Durham
Journal:  Pain Rep       Date:  2017-10-17

8.  Effect of Non-invasive Vagus Nerve Stimulation on Resting-State Electroencephalography and Laser-Evoked Potentials in Migraine Patients: Mechanistic Insights.

Authors:  Eleonora Vecchio; Iege Bassez; Katia Ricci; Cristina Tassorelli; Eric Liebler; Marina de Tommaso
Journal:  Front Hum Neurosci       Date:  2018-09-13       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.